Wells Fargo
DFTX

Wells Fargo’s Definium Therapeutics DFTX Stock Holding History

Wells Fargo’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$755K Sell
39,973
-67,084
-63% -$1.14M ﹤0.01% 3913
2025
Q4 		$1.43M Buy
107,057
+50,562
+89% +$626K ﹤0.01% 3690
2025
Q3 		$666K Buy
56,495
+8,778
+18% +$81.9K ﹤0.01% 4095
2025
Q2 		$310K Buy
47,717
+10,301
+28% +$67.7K ﹤0.01% 4478
2025
Q1 		$219K Sell
37,416
-2,558
-6% -$18.3K ﹤0.01% 4640
2024
Q4 		$278K Buy
39,974
+15,269
+62% +$105K ﹤0.01% 4585
2024
Q3 		$141K Sell
24,705
-665
-3% -$4.63K ﹤0.01% 4810
2024
Q2 		$183K Buy
25,370
+22,787
+882% +$199K ﹤0.01% 4571
2024
Q1 		$24.3K Buy
2,583
+2,324
+897% +$13.3K ﹤0.01% 5525
2023
Q4 		$948 Buy
259
+16
+7% +$48 ﹤0.01% 6236
2023
Q3 		$761 Sell
243
-2
-0.8% -$8 ﹤0.01% 6258
2023
Q2 		$875 Buy
245
+17
+7% +$59 ﹤0.01% 6347
2023
Q1 		$723 Buy
228
+3
+1% +$10 ﹤0.01% 6470
2022
Q4 		$495 Buy
+225
New +$625 ﹤0.01% 6389
2022
Q3 		– Sell
-34
Closed – – 7097
2022
Q2 		$0 Sell
34
-4,710
-99% -$59.6K ﹤0.01% 7227
2022
Q1 		$79K Sell
4,744
-8,705
-65% -$151K ﹤0.01% 5434
2021
Q4 		$279K Buy
13,449
+11,703
+670% +$374K ﹤0.01% 5075
2021
Q3 		$61K Buy
1,746
+1,712
+5,035% +$74K ﹤0.01% 5549
2021
Q2 		$2K Buy
+34
New +$1.78K ﹤0.01% 6546

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wells Fargo's DFTX Position: Q1 2026 in Review

Wells Fargo reduced its Definium Therapeutics (DFTX) stake by 63% in Q1 2026, selling an estimated $1.14M and leaving 39,973 shares worth $755K. The position accounts for ﹤0.01% of the portfolio, ranked #3913.

Wells Fargo first reported a position in DFTX in Q2 2021 and has held it in 19 quarters since. The position peaked at $1.43M in Q4 2025. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • Wells Fargo held 39,973 shares of Definium Therapeutics worth $755K as of Q1 2026.
  • Wells Fargo sold 67,084 Definium Therapeutics shares in Q1 2026, an estimated $1.14M.
  • Definium Therapeutics made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #3913 holding.
  • Wells Fargo first reported a position in Definium Therapeutics in Q2 2021 and has held it in 19 quarters since.
  • Wells Fargo's Definium Therapeutics position peaked at $1.43M in Q4 2025.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.